UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
P P- P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 PA PB PC PD PE PF PG PH PI PK PL PM PN PO PP PQ PR PS PT PU PV PW PX PY
PA PA- PAA PAC PAD PAF PAG PAH PAI PAK PAL PAM PAN PAP PAR PAS PAT PAU PAV PAW PAX PAY PAZ
selected terms: 885 page 1 of 9

1. 1-(p-Acetylbenzenesulfonyl)-3-Cyclohexylurea
[A sulfonylurea with oral hypoglycemic properties that is used in the treatment of Type II diabetes mellitus. Acetohexamide lowers blood sugar by stimulating insulin release from the pancreas and increases the sensitivity of beta cells to glucose stimulus. This drug also increases the sensitivity of insulin receptors in muscle, liver, and adipose tissue thereby promoting glucose transport across cell membranes. This results in better controlled blood glucose levels. (NCI05) ( NCI )] (UMLS (NCI) C0000992) =Organic Chemical; Pharmacologic Substance ;
51. PAF acetylhydrolase
[A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA. ( MSH )] (UMLS (CSP) C0914069) =Amino Acid, Peptide, or Protein; Enzyme ;
2. 2 PAM
[ ] (UMLS (CSP) C0071808) =Organic Chemical; Pharmacologic Substance ;
=Pralidoxime Compounds;
[AD900] ANTIDOTES/DETERRENTS, OTHER =Pralidoxime Chloride
52. Pafenolol
(UMLS (NCI) C0069942) =Organic Chemical; Pharmacologic Substance ;
3. 2-(p-Aminobenzenesulfonamido)-5-methylthiadiazole
[A broad-spectrum sulfanilamide and a synthetic analog of para-aminobenzoic acid (PABA) with antibacterial property. Sulfamethizole competes with PABA for the bacterial enzyme dihydropteroate synthase, thereby preventing the incorporation of PABA into dihydrofolic acid, the immediate precursor of folic acid. This leads to an inhibition of bacterial folic acid synthesis and de novo synthesis of purines and pyrimidines, ultimately resulting in cell growth arrest and cell death. ( NCI )] (UMLS (NCI) C0038687) =Organic Chemical; Pharmacologic Substance =Sulfathiazoles;
[AM650] SULFONAMIDE/RELATED ANTIMICROBIALS =SULFAMETHIZOLE 250 MG;
SULFAMETHIZOLE 500 MG;
SULFAMETHIZOLE 0.5 GM;
SULFAMETHIZOLE 400 MG;
SULFAMETHIZOLE 800 MG;
53. PAG
[Encoded by human PAG Gene, ubiquitous 432-aa 47-kDa Phosphoprotein Associated with GEMs is a type III plasma transmembrane adaptor protein located predominantly in membrane rafts (GEMs), associated with FYN and CSK tyrosine kinase, and thought to be involved in T cell activation and immunoreceptor signal transduction. PAG contains a 16-aa extracellular domain, a transmembrane domain, a putative palmitoylation site, and a 397-aa cytoplasmic tail with 9 potential tyrosine phosphorylation sites, ITAM-like motifs, and multiple putative casein kinase II and protein kinase C phosphorylation sites. Two Pro-rich sequences may bind to SH3 domains. PAG recruits CSK to the plasma membrane, independent of FYN. After T-cell activation, association with CSK, but not FYN, decreases. PAG/CSK may increase the signaling threshold for initiating an immune response, keeping lymphocytes in a resting state. (NCI) ( NCI )] (UMLS (NCI) C1335407) Phosphoprotein Associated with GEMs;
Phosphoprotein Associated with Glycosphingolipid-Enriched Microdomains;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
4. 2-(p-Aminophenyl)-2-ethylglutarimide
[USP lists as an antineoplastic and an "adrenocortical suppressant." ( CSP )] (UMLS (NCI) C0002555) =Organic Chemical; Pharmacologic Substance ;
54. Paganism
(UMLS (HL7) C0681178) =Idea or Concept ;
=Religious Affiliation;
5. p aminobenzoate
[member of the vitamin B complex although not an essential nutrient for humans; formerly a common sunscreen agent until found to also be a sensitizer; potassium salt is used therapeutically in fibrotic skin disorders. ( CSP )] (UMLS (CSP) C0178789) =Organic Chemical; Pharmacologic Substance ;
=benzoate;
=PROCAINE;
55. Page's Saline
[0.12 g NaCl, 0.004 g MgSO, 0.004 g, CaCl, 0.142 g Na2HPO4 and 0.136 g KH2PO4 per liter of distilled water. Maintain Acanthaoemba viability. ( HL7V3.0 )] (UMLS (HL7) C1561485) =Intellectual Product =MaterialEntityAdditive;
6. p aminohippurate
[ ] (UMLS (CSP) C0086761) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =phenylamide;
56. pager
[A small wireless radio receiver designed to be carried by a person, to give an indication when activated by the reception of a radio signal containing its specific code, and to display a short messages in a text-only format. ( NCI )] (UMLS (HL7) C1550704) =Manufactured Object =TelecommunicationAddressUse;
7. P-ARTIC
[Periarticular ( HL7V3.0 )] (UMLS (NCI) C0595695) =Functional Concept ;
=RouteBySite;
=Injection, periarticular;
57. Pages
(UMLS (HL7) C1548329) =Idea or Concept =Quantity limited request;
8. PA
[A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica. (NCI) ( NCI )] (UMLS (NCI) C0030266) =Geographic Area ;
◊ [A country in Central South America, northeast of Argentina. (NCI) ( NCI )] (UMLS (NCI) C0030428) Geographic Area ; ◊ [A state in the mid-atlantic United States. Its capital is Harrisburg. ( NCI )] (UMLS (NCI) C0030853) Geographic Area
58. Pages
[Used where pages of response has limitations. ( HL7V3.0 )] (UMLS (HL7) C1553413) =Qualitative Concept =QueryQuantityUnit;
9. Pa
[A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10(e-4) pounds per square inch. ( NCI )] (UMLS (NCI) C0439473) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens
59. Pages's Saline
(UMLS (HL7) C1550084) =Biomedical or Dental Material; Inorganic Chemical =Additive/Preservative;
10. PA-1-STK Ovarian Carcinoma Vaccine
[A cell-based gene transfer with potential antineoplastic activity. PA-1 STK ovarian carcinoma vaccine is produced by transducing the ovarian cancer cell line, PA-1, with a retrovirus (STK) encoding the herpes simplex thymidine kinase (HSV-tk) gene, resulting in a cell line that permanently expresses the HSV tk gene. Upon transfection into malignant cells, this vaccine is capable of sensitizing tumor cells in response to an antiviral drug such as ganciclovir, which is readily phosphorylated by the TK enzyme to its active form. Administration of ganciclovir following PA-1 STK transfection results in enhanced cytotoxicity of the transfected tumor cells. Additionally, adjacent non-transfected cells are killed by the activated antiviral drug, a phenomena referred to as the bystander effect and which is commonly described with this type of suicide-gene transfer. ( NCI )] (UMLS (NCI) C0393067) =Pharmacologic Substance; Immunologic Factor ;
60. Paget Cell Neoplasm
[A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells). Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum. — 2004 ( NCI )] (UMLS (NCI) C1368019) Paget Disease;
Paget's Cell Neoplasm;
Paget's Disease =Neoplastic Process
11. PA-144
(UMLS (NCI) C0702001) =Carbohydrate; Indicator, Reagent, or Diagnostic Aid; Antibiotic
61. Paget Disease and Intraductal Carcinoma of the Breast
[Paget disease of the breast associated with the presence of a usually high grade ductal carcinoma in situ in the lactiferous glands. ( NCI )] (UMLS (NCI) C0279566) =Neoplastic Process
12. PACAP
[A multi-function neuropeptide that acts throughout the body by elevating intracellular cyclic AMP level via its interaction with PACAP RECEPTORS. Although first isolated from hypothalamic extracts and named for its action on the pituitary, it is widely distributed in the central and peripheral nervous systems. PACAP is important in the control of endocrine and homeostatic processes, such as secretion of pituitary and gut hormones and food intake. ( MSH )] (UMLS (CSP) C0071163) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
62. Paget Disease of the Breast with Invasive Ductal Carcinoma
[Paget disease involving the skin overlying the mammary gland, accompanied by invasive ductal breast carcinoma. ( NCI )] (UMLS (NCI) C0279567) =Neoplastic Process
13. PACAP Receptor, Type II
[Encoded by human VIPR1 Gene (GPCR Family 2), Vasoactive Intestinal Peptide Receptor 1 appears to be expressed in brain, heart, kidney, liver, colonic epithelia, and placenta. The 457-amino acid 51.5 kD (precursor) G protein-coupled receptor contains seven transmembrane domains. Distinct subsets of neural, respiratory, gastrointestinal, and immune cells bear high-affinity VIP G protein receptors, capable of activating adenylate cyclase. (OMIM, Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C0534281) =Amino Acid, Peptide, or Protein; Receptor
63. Paget Disease of the Penis
[A premalignant condition morphologically characterised by the presence of the characteristic Paget cells in the intraepithelial tissue of the penis. It presents as a smooth raised reddish area that may or may not be painful. — 2003 ( NCI )] (UMLS (NCI) C0221286) =Neoplastic Process ;
14. pace
[2.5 [ft_br] ( HL7V3.0 )] (UMLS (HL7) C1552930) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens
64. Paget Disease of the Scrotum
(UMLS (NCI) C0238330) =Disease or Syndrome
15. Pace spike
(UMLS (HL7) C1548552) =Idea or Concept =Annotations;
65. Paget Disease of the Vulva
(UMLS (NCI) C1275217) Paget's Disease of the Vulva;
Paget's Disease of Vulva;
Vulva Paget's Disease;
Vulvar Paget's Disease;
=Neoplastic Process
16. Pace, Gen-Probe
(UMLS (HL7) C1548738) =Laboratory Procedure =Specimen Collection Method;
66. Paget Involvement
(UMLS (NCI) C1335291) =Finding ;
17. Pacemaker
(UMLS (HL7) C1546728) =Intellectual Product =Specimen Source Codes;
67. Paget's Disease of Sternum
(UMLS (NCI) C1336505) Paget's Disease of the Sternum;
Sternal Paget Disease;
Sternal Paget's Disease =Disease or Syndrome
18. Pacific Coast States
[The area in the United States comprised of the following states: Alaska, Washington, Oregon, California and Hawaii. ( NCI )] (UMLS (NCI) C0684036) =Geographic Area ;
68. Pagetoid Proliferation
(UMLS (NCI) C1335292) Pagetoid Spread;
=Finding ;
19. Pacific Islander
[a person having origins in any of the original people of Hawaii, Guam, Samoa, or other Pacific Islands. ( CSP )] (UMLS (CSP) C0242191) =Population Group ;
=ethnic group;
=Hawaiian
69. Pagetoid Reticulosis
[A variant of mycosis fungoides, characterized by an exclusively intraepidermal atypical (cerebriform) lymphocytic infiltrate. Patients present with a localized psoriasiform or hyperkeratotic patch or plaque, usually in the extremities. Extracutaneous dissemination of the disease has never been reported. ( NCI )] (UMLS (NCI) C1367970) =Neoplastic Process ;
20. Pacific Islands
[The islands of the Pacific Ocean divided into MICRONESIA; MELANESIA; and POLYNESIA (including NEW ZEALAND). The collective name Oceania includes the aforenamed islands, adding AUSTRALIA; NEW ZEALAND; and the Malay Archipelago (INDONESIA). (Webster's New Geographical Dictionary, 1988, p910, 880) ( MSH )] (UMLS (CSP) C0030168) =Geographic Area =Area;
=Hawaii;
PH;
70. PAH
[Polycyclic aromatic hydrocarbons (PAH) are a large class of organic compounds containing two or more fused aromatic rings made up of carbon and hydrogen atoms. They have high melting and boiling-points, low vapour pressure, water solubility, and are highly lipophilic. PAH are produced during incomplete combustion or pyrolysis of organic matter, are found in cigarette smoke, motor vehicle exhaust, used motor lubricating oil, broiled meat, coal tar, crude oil, creosote, roofing tar, dyes, plastics, and pesticides. Some members of PAH class were shown to have carcinogenic, genotoxic, and immunotoxic properties, developmental toxicity and affect reproductive health. (NCI) ( NCI )] (UMLS (CSP) C0032458) =Organic Chemical ;
=carbopolycyclic compound;
=Anthracenes;
Benzocycloheptenes;
fluorene;
Indenes;
Naphthacenes;
naphthalene;
Phenanthrenes;
spiro compound;
21. Pacific yew tree
[ ] (UMLS (CSP) C0330203) =Plant
71. PAI
[synthesized and secreted locally from vascular endothelial cells; primary physiologic inhibitor of tissue plasminogen activator; also inhibits urokinase; implicated in thrombotic and hemorrhagic disorders. ( CSP )] (UMLS (CSP) C0032145) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=enzyme inhibitor;
22. PacificCoastAthapaskan
(UMLS (HL7) C1698108) =Language =Athapaskan;
=OregonAthapaskan;
CaliforniaAthapaskan;
72. Pai
(UMLS (HL7) C1698947) =Idea or Concept =Yuman;
=Havasupai;
23. Pacinian Neurofibroma
(UMLS (NCI) C0334599) =Neoplastic Process
73. paid non-payee payable prior-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555515) paid non-payee payable prior-period electronic count;
=Intellectual Product =InvoiceElementPaid;
24. PACK EXT AUDITORY CANAL
[ ] (UMLS (ICD9CM) C0198057) =Therapeutic or Preventive Procedure
74. paid non-payee payable prior-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555518) =Intellectual Product =InvoiceElementPaid;
25. Package
[A material intended to hold other materials for purposes of storage or transportation ( HL7V3.0 )] (UMLS (HL7) C1553449) =Manufactured Object =ContainerEntityType;
=Kit;
Compliance Package;
RigidContainerEntityType;
NonRigidContainerEntityType
75. paid non-payee payable prior-period manual count
[Identifies the total number of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555517) =Intellectual Product =InvoiceElementPaid;
26. Packaged APC
(UMLS (HL7) C1547528) =Intellectual Product =Reimbursement Type Code;
76. paid non-payee payable same-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555512) =Intellectual Product =InvoiceElementPaid;
27. Packaged as part of partial hospitalization per diem or daily mental health service per diem
(UMLS (HL7) C1547519) =Intellectual Product =Packaging Status Code;
77. paid non-payee payable same-period electronic count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555511) =Intellectual Product =InvoiceElementPaid;
28. Packaged service (status indicator N, or no HCPCS code and certain revenue codes)
(UMLS (HL7) C1547518) =Intellectual Product =Packaging Status Code;
78. paid non-payee payable same-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555514) =Intellectual Product =InvoiceElementPaid;
29. packaging material
[form in which product is processed or wrapped and labeled; includes containers, packaging methods and packaging intended to be used for storage, shipment or preparation of foods, drugs, etc. ( CSP )] (UMLS (CSP) C0178791) =Manufactured Object =Material;
79. paid non-payee payable same-period manual count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date) that do not match a specified payee (e.g. pay patient) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555513) =Intellectual Product =InvoiceElementPaid;
30. Packaging Status Code
(UMLS (HL7) C1547847) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Not packaged;
Packaged service (status indicator N, or no HCPCS code and certain revenue codes);
Packaged as part of partial hospitalization per diem or daily mental health service per diem;
80. paid nullified prior-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date), subsequently nullified in the specified period and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1553928) =Intellectual Product =InvoiceElementPaid;
31. PACKED CELL TRANSFUSION
[ ] (UMLS (ICD9CM) C0178192) =Therapeutic or Preventive Procedure
81. paid nullified prior-period electronic count
[Identifies the total number of all Invoice Groupings that were paid prior to the specified time period (based on payment date), subsequently nullified in the specified period and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1553927) =Intellectual Product =InvoiceElementPaid;
32. Packed Cells
(UMLS (HL7) C1547247) =Intellectual Product =Blood Product Code;
82. paid nullified prior-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date), subsequently nullified in the specified period and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1553930) =Intellectual Product =InvoiceElementPaid;
33. Packed Cells - Neonatal
(UMLS (HL7) C1547249) =Intellectual Product =Blood Product Code;
83. paid nullified prior-period manual count
[Identifies the total number of all Invoice Groupings that were paid prior to the specified time period (based on payment date), subsequently nullified in the specified period and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1553929) =Intellectual Product =InvoiceElementPaid;
34. Packed Red Blood Cell Transfusion
(UMLS (NCI) C0199962) =Therapeutic or Preventive Procedure
84. paid nullified same-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date), subsequently nullified in the specified period and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1553924) =Intellectual Product =InvoiceElementPaid;
35. Packet
[A paper ( HL7V3.0 )] (UMLS (HL7) C1553452) =Intellectual Product =NonRigidContainerEntityType;
85. paid nullified same-period electronic count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date), subsequently cancelled in the specified period and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1553923) =Intellectual Product =InvoiceElementPaid;
36. Packing
[A material used in medical and dental practice for filling a natural cavity or deep or tunneled wound. The packing absorbs drainage from the wound so the tissues can heal from the inside out. Without the packing, the wound could close without healing the deep areas of the wound. ( NCI )] (UMLS (NCI) C1289829) Packing Material =Medical Device ;
86. paid nullified same-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date), subsequently nullified in the specified period and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1553926) =Intellectual Product =InvoiceElementPaid;
37. Paclitaxel/Pegfilgrastim
(UMLS (NCI) C1328068) =Therapeutic or Preventive Procedure; ;
87. paid nullified same-period manual count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date), subsequently nullified in the specified period and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1553925) =Intellectual Product =InvoiceElementPaid;
38. Paclitaxel/Prinomastat
(UMLS (NCI) C0935712) =Therapeutic or Preventive Procedure
88. paid payee payable prior-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555508) =Intellectual Product =InvoiceElementPaid;
39. Paclitaxel/PSC 833
(UMLS (NCI) C0281559) =Therapeutic or Preventive Procedure ;
89. paid payee payable prior-period electronic count
[Identifies the total number of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555507) =Intellectual Product =InvoiceElementPaid;
40. Paclitaxel/Quinine
(UMLS (NCI) C0281383) =Therapeutic or Preventive Procedure ;
90. paid payee payable prior-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555510) =Intellectual Product =InvoiceElementPaid;
41. Paclitaxel/R101933
(UMLS (NCI) C1134557) =Therapeutic or Preventive Procedure ;
91. paid payee payable prior-period manual count
[Identifies the total number of all Invoice Groupings that were paid prior to the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555509) =Intellectual Product =InvoiceElementPaid;
42. Paclitaxel/SU5416
(UMLS (NCI) C0879481) =Therapeutic or Preventive Procedure
92. paid payee payable same-period electronic amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555504) =Intellectual Product =InvoiceElementPaid;
43. Paclitaxel/Suramin
(UMLS (NCI) C1327872) =Therapeutic or Preventive Procedure ;
93. paid payee payable same-period electronic count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted electronically. ( HL7V3.0 )] (UMLS (HL7) C1555503) =Intellectual Product =InvoiceElementPaid;
44. Paclitaxel/Thiotepa
(UMLS (NCI) C0281637) =Therapeutic or Preventive Procedure
94. paid payee payable same-period manual amount
[Identifies the total net amount of all Invoice Groupings that were paid during the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555506) =Intellectual Product =InvoiceElementPaid;
45. Paclitaxel/Topotecan
(UMLS (NCI) C0281304) =Therapeutic or Preventive Procedure ;
95. paid payee payable same-period manual count
[Identifies the total number of all Invoice Groupings that were paid during the specified time period (based on payment date) that match a specified payee (e.g. pay provider) and submitted manually. ( HL7V3.0 )] (UMLS (HL7) C1555505) =Intellectual Product =InvoiceElementPaid;
46. Paclitaxel/Vinorelbine
(UMLS (NCI) C0338263) =Therapeutic or Preventive Procedure
96. pain
[unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings. ( CSP )] (UMLS (CSP) C0030193) =Sign or Symptom =neural manifestation;
sensation =back pain;
Cefalea (ex N02 N89 R09);
hyperalgesia;
chronic pain;
pain threshold;
oral facial pain;
cancer pain;
ABDMNAL PAIN UNSPCF SITE;
Arthralgia;
back pain;
CERVICALGIA;
Chest pain;
Earache;
Aangezichtspijn;
Flank Pain;
Glossalgia;
Cefalea (ex N02 N89 R09);
Neuralgia;
Pain, Intractable;
Pain, Postoperative;
Pelvic Pain
47. Paclitaxel/VX-710
(UMLS (NCI) C0393036) =Therapeutic or Preventive Procedure
97. Pain
[Facilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as "acute pain services". (From Br Med Bull 1991 Jul;47(3):762-85) ( MSH )] (UMLS (HL7) C0242936) =Manufactured Object; Health Care Related Organization =Clinic/Center;
48. pactamycin
[Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis. ( MSH )] (UMLS (CSP) C0030178) =Organic Chemical; Antibiotic ;
98. Pain
(UMLS (HL7) C1549543) =Functional Concept =Administration Method;
49. PAD/TMTX
(UMLS (NCI) C0279256) =Therapeutic or Preventive Procedure
99. Pain and other symptoms associated with female genital organs
(UMLS (ICD9CM) C0156401) =Sign or Symptom
50. PADRE 965.10
[Pan-DR epitope (PADRE) 965.10 is a helper peptide. PADRE peptides have been shown the capacity to deliver help for antibody responses in vivo. They were also found to be able to provide significant helper T-cell activity in vivo. Acts as an adjuvant. ( NCI )] (UMLS (NCI) C0338209) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
100. Pain Assessment
[The evaluation of pain complaints. Measurements should be objective on the part of the practitioner, based on subjective information from the patient. Measurements may also be indirect, by such assessments as respiratory rate and effort, withdrawal, guarding, or other appropriate assessment techniques. ( NCI )] (UMLS (NCI) C0030198) =Diagnostic Procedure ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM